Eli Lilly Has Exclusivity Over Weight Loss Drug, FDA Says

By Spencer Brewer · February 21, 2025, 8:24 PM EST

The U.S. Food and Drug Administration asked a Texas federal court to reject a request for an injunction that would allow compounding pharmacies to produce a lucrative weight loss drug, saying...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

Outsourcing Facilities Association et al v. United States Food and Drug Administration et al

Case Number

Court

Texas Northern

Nature of Suit

Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

October 07, 2024

Recent Articles By Spencer

January 23, 2025
15 States Reach $7.4B Settlement With Sackler Family
January 14, 2025
Dispute Over Eli Lilly Weight Loss Drug Reignited
December 06, 2024
5th Circ. Judge Notes Inconsistencies In Medicare Rate Policy
November 27, 2024
X Corp Says Gov't Trying To 'Muzzle' Doc In Bitter HIPAA Case
October 03, 2024
Texas Takes Aim At Insulin Manufacturers For Price-Gouging
August 29, 2024
Doctor Wants Stepson Barred From Selling Medial Device
June 27, 2024
Texas DAs Escape Defendant Class Cert. In Abortion Case
April 11, 2024
Ernest Health Hit With Suit After Cybercriminal Data Breach
April 04, 2024
5th Circ. Scrutinizes Data-Tracking On La. Health Provider Site
March 18, 2024
Texas Hospital Loses Bid To Dismiss Patients' Hack Suit